Caption Management, LLC Cure Vac N.V. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $693,000 - $1.5 Million	300,000 New	300,000 $1.02 Million
Q1 2022 May 13, 2022	SELL	$14.73 - $35.25 $1.69 Million - $4.05 Million	-115,000 Reduced 57.5%	85,000 $1.67 Million
Q4 2021 Feb 11, 2022	SELL	$33.72 - $48.22 $3.52 Million - $5.03 Million	-104,400 Reduced 34.3%	200,000 $6.86 Million
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $7.04 Million - $10.7 Million	143,000 Added 88.6%	304,400 $16.6 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $6.62 Million - $14.8 Million	116,400 Added 258.67%	161,400 $11.9 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $3.59 Million - $5.68 Million	45,000 New	45,000 $4.12 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.